Study of Temzolomide and Gleevec in Advanced Melanoma

NCT00667953 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Difficulty enrolling subjects

Conditions

Melanoma
Advanced Melanoma

Interventions

DRUG: Gleevec
DRUG: Temodar

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators

[object Object]